CATALYST PHARMACEUTICALS, INC. - Director's Dealing 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-03-05

Reporting Person: INGENITO GARY (Chief Med. & Reg. Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-05	Common stock, par value $0.001 per share	M	44904	$2.24	Acquired	113777	Direct
2025-03-05	Common stock, par value $0.001 per share	S	44904	$22.09	Disposed	68873	Direct
2025-03-06	Common stock, par value $0.001 per share	M	180096	$2.24	Acquired	248969	Direct
2025-03-06	Common stock, par value $0.001 per share	S	180096	$21.67	Disposed	68873	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-05	Options to purchase common stock	$2.24	M	44904	Disposed	2025-12-19	Common Stock (44904)	Direct
2025-03-06	Options to purchase common stock	$2.24	M	180096	Disposed	2025-12-19	Common Stock (180096)	Direct

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in a range between $22.00 and $22.285 per share.

F3: Represents a weighted average price for the shares sold. Shares were sold in a range between $21.60 and $21.95 per share.

F4: Options vested in three annual tranches beginning on December 19, 2019.